MMP9 and diabetes mellitus: The changes in circulating levels of ET-1 and MMP-9 might be associated with the possible mechanisms such as endothelial dysfunction that might help to explain why people with MetS have a higher chance of developing cardiovascular diseases, diabetes mellitus and cancers.